Cargando…
MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs
BACKGROUND: Accumulating studies reveal that aberrant microRNA (miRNA) expression can affect the development of chemotherapy drug resistance by modulating the expression of relevant target proteins. The aim of this study was to investigate the role of miR-133b in the development of drug resistance i...
Autores principales: | Chen, Shuo, Jiao, Jin-Wen, Sun, Kai-Xuan, Zong, Zhi-Hong, Zhao, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577257/ https://www.ncbi.nlm.nih.gov/pubmed/26396496 http://dx.doi.org/10.2147/DDDT.S87526 |
Ejemplares similares
-
Glutathione S-transferase π: a potential role in antitumor therapy
por: Dong, Shu-Chen, et al.
Publicado: (2018) -
Blood Glutathione S-Transferase-π as a Time Indicator of Stroke Onset
por: Turck, Natacha, et al.
Publicado: (2012) -
Significance of Nuclear Glutathione S‐Transferase π in Resistance to Anti‐cancer Drugs
por: Goto, Shinji, et al.
Publicado: (2002) -
Clinical significance of P-glycoprotein and glutathione S-transferase π expression in gallbladder carcinoma
por: MA, QING-JIU, et al.
Publicado: (2014) -
Urinary π-glutathione S-transferase Predicts Advanced Acute Kidney Injury Following Cardiovascular Surgery
por: Shu, Kai-Hsiang, et al.
Publicado: (2016)